Envision Healthcare Corporation (NYSE:EVHC):
Long-Term Envision (EVHC) Investors: Johnson Fistel Investigates Envision Healthcare Corporation; Encourages Long-Term Investors to Contact the Firm.
In the market the company is trading up by 1.31% since yesterday’s close of $42.60.
Envision Healthcare Corporation, launched on June 10, 2016, is a provider of healthcare services. The Company offers a range clinical solutions, including physician-led services, medical transportation, ambulatory services and post-acute services. The Company operates through three segments: physician services, medical transportation and ambulatory services. The physician services segment includes the Business’s hospital-based and non-hospital-based physician services business. The medical transportation segment includes the Business’s community-based medical transportation services, including emergency 911, non-emergency, managed transportation, air ambulance and disaster response services. The ambulatory services segment includes the Business’s ambulatory surgery business, which acquires, develops, owns and operates ambulatory surgery centers (ASCs) and surgical hospitals in partnership with physicians and health systems. As of March 31, 2017, the Company had physician services contracts covering more than 1,600 clinical departments at healthcare facilities in 45 states and the District of Columbia, provided medical transportation services pursuant to more than 4,100 contracts and arrangements in 38 states and the District of Columbia, and owned and operated 264 ASCs in 35 states and the District of Columbia..
Company shares last traded at $42.60 which is just a bit below the 50 day moving average which is $44.16 and which is well below the 200 day moving average of $53.20. The 50 day moving average went down by -3.54% and the 200 day average went down by -19.93%.
In the latest earnings report the EPS was $-5.50 and is projected to be $1.40 for the current year with 117,076,000 shares presently outstanding. Next quarter’s EPS is expected be $0.99 and the next full year EPS is projected to be $3.86.
Traders are a little more bullish on the company as shown by the change in short interest. The firm recorded a fall in short interest of -0.72% as of the latest report on October 13, 2017. Short interest fell 121,858 over that timeframe. With short interest at 16,754,731 and short average daily volume at 1,607,670, days to cover is 10.0 and the percentage of shorted shares is 0.09% as of October 13.